Fatigue, frequently encountered in medical practice, often presents a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive approach to diagnosing and managing fatigue, thereby enhancing patient care.
Fatigue is a common complaint, yet it often remains underdiagnosed due to its subjective nature and the absence of specific diagnostic tests. It can be a symptom of various underlying conditions, including anemia, thyroid disorders, sleep disorders, mental health issues, and chronic illnesses such as cancer or heart disease.
A thorough history and physical examination are essential for diagnosing fatigue. Clinicians should evaluate the duration, severity, and impact of fatigue on daily activities. Additionally, the presence of other symptoms such as weight loss, fever, or pain might indicate a specific underlying condition. Laboratory tests, including complete blood count, thyroid function tests, and sleep studies, can also be helpful.
Management of fatigue should be tailored to the underlying cause. For instance, treatment of anemia or hypothyroidism often results in significant improvement. In cases of chronic fatigue syndrome or fibromyalgia, a multidisciplinary approach involving cognitive-behavioral therapy, graded exercise therapy, and pharmacological treatment can be beneficial. Lifestyle modifications, including regular exercise, a balanced diet, and adequate sleep, are also crucial.
Addressing fatigue in medical practice requires a comprehensive approach, encompassing careful assessment, appropriate diagnostic testing, and tailored management strategies. By recognizing and effectively managing fatigue, healthcare professionals can significantly improve patients' quality of life and overall health outcomes.
1.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
2.
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona
3.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
4.
In early dementia, SSRIs enhance cognition and major depression.
5.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
1.
Oncologic Emergencies: Diagnosis and Treatment
2.
Strategic Standards in Hematology for Specialists
3.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
4.
Advanced Breakthroughs in Hematology and Patient Outcomes
5.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part IX
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation